From: Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas
PROPORTION METHYLATED
BRCA1
MLH1
FANCF
Primary, no chemotherapy
6/91 (6.6%)
3/93 (3.2%)
Primary, post neoadjuvant chemo
2/11 (18%)
1/11 (9.1%)
0/10
Recurrent*
2/31 (6.5%)
0/30
0/31 (0%)
Total (2.2%)
10/133 (7.5%)
4/134 (3.0%)
3/134